Probing the functional consequence and clinical relevance of <scp> CD320 </scp> p.E88del, a variant in the transcobalamin receptor gene

MLA

Faith Pangilinan, et al. “Probing the Functional Consequence and Clinical Relevance of CD320 p.E88del, a Variant in the Transcobalamin Receptor Gene.” American Journal of Medical Genetics Part A, vol. 188, Feb. 2022, pp. 1124–41. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....30bed215cff61b933b6a2cd3e357f290&authtype=sso&custid=ns315887.

APA

Faith Pangilinan, David Watkins, David Bernard, Yue Chen, Ningzheng Dong, Qingyu Wu, Hatice Ozel‐Abaan, Manjit Kaur, Michele Caggana, Mark Morrissey, Marilyn L. Browne, James L. Mills, Carol Van Ryzin, Oleg Shchelochkov, Jennifer Sloan, Charles P. Venditti, Kyriakie Sarafoglou, David S. Rosenblatt, Denise M. Kay, & Lawrence C. Brody. (2022). Probing the functional consequence and clinical relevance of CD320 p.E88del, a variant in the transcobalamin receptor gene. American Journal of Medical Genetics Part A, 188, 1124–1141.

Chicago

Faith Pangilinan, David Watkins, David Bernard, Yue Chen, Ningzheng Dong, Qingyu Wu, Hatice Ozel‐Abaan, et al. 2022. “Probing the Functional Consequence and Clinical Relevance of CD320 p.E88del, a Variant in the Transcobalamin Receptor Gene.” American Journal of Medical Genetics Part A 188 (February): 1124–41. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....30bed215cff61b933b6a2cd3e357f290&authtype=sso&custid=ns315887.